Αbout 75% of all breast tumors are ERα positive and thus tamoxifen is the most widely used therapy for breast cancer leading to tumor stabilization in about 50% of previously untreated patients with metastatic breast cancer3, 5. Here, ESR1 is linked to neoplasm.